期刊文献+

亮丙瑞林与孕三烯酮片对子宫内膜异位症术后患者生殖激素水平及短期复发的影响 被引量:4

The Effect of Leuprolide and Gestrinone Tablets on Reproductive Hormone Levels and Short-term Recurrence in Patients with Endometriosis
在线阅读 下载PDF
导出
摘要 目的探讨亮丙瑞林与孕三烯酮片对子宫内膜异位症(EMT)术后患者生殖激素水平及短期复发的影响。方法便利选择2019年1月—2020年1月在该院行子宫内膜异位症手术治疗患者97例作为研究对象,采用随机数表法的原则将其分为A组(n=48)及B组(n=49)。A组给予孕三烯酮片治疗,B组给予亮丙瑞林治疗。比较分析两组临床疗效,治疗前、治疗3个月后的生殖激素水平及短期复发情况。结果B组治疗总有效率(97.96%)高于对照组(83.33%),差异有统计学意义(χ^(2)=4.547,P=0.013);治疗后,相比A组促卵泡生成激素(5.42±1.29)mmol/mL、促黄体生成激素(5.79±1.24)mmol/mL、雌二醇(86.49±10.41)pg/mL,B组促卵泡生成激素(3.79±1.16)mmol/mL、促黄体生成激素(4.05±1.01)mmol/mL、雌二醇(75.42±9.45)pg/mL水平均低,差异有统计学意义(t=6.547、7.585、5.486,P<0.001);B组不良反应(4.08%)略低于A组(10.42%),但差异无统计学意义(χ^(2)=0.661,P=0.228);B组复发率(4.08%)明显低于A组(18.75%),差异有统计学意义(χ^(2)=5.189,P=0.023)。结论亮丙瑞林较孕三烯酮片治疗EMT术后患者疗效更佳,有利于抑制生殖激素水平,降低术后短期复发率,且未见明显不良反应增加,安全可行。 Objective To investigate the effects of leuprolide and gestrinone tablets on reproductive hormone levels and short-term recurrence in patients with endometriosis after surgery.Methods Ninety-seven patients who underwent endometriosis surgery in the hospital from January 2019 to January 2020 were conveniently selected as the research objects,and they were divided into group A(n=48)and group B(n=49)using the principle of random number table method.Group A was treated with gestrinone tablets,and group B was treated with leuprolide.The clinical effects,the reproductive hormone levels before and after 3 months of treatment,and short-term recurrence of the two groups were compared and analyzed.Results The total effective rate of treatment in group B(97.96%)was higher than that of the control group(83.33%),and the difference was statistically significant(χ^(2)=4.547,P=0.013);after treatment,compared with group A follicle-stimulating hormone(5.42±1.29)mmol/mL,luteinizing hormone(5.79±1.24)mmol/mL,estradiol(86.49±10.41)pg/mL,group B follicle-stimulating hormone(3.79±1.16)mmol/mL,luteinizing hormone(4.05±1.01)mmol/mL,and estradiol(75.42±9.45)pg/mL all lower,and the difference was statistically significant(t=6.547,7.585,5.486,P<0.001);adverse reactions in group B(4.08%)were slightly lower than those in group A(10.42%),but the difference was not statistically significant(χ^(2)=0.661,P=0.228);the recurrence rate of group B(4.08%)was significantly lower than group A(18.75%),the difference was statistically significant(χ^(2)=5.189,P=0.023).Conclusion Leuprolide is more effective than gestrinone in the treatment of patients with EMT after surgery.It is beneficial to inhibit the level of reproductive hormones and reduce the short-term recurrence rate after surgery.There is no significant increase in adverse reactions.It is safe and feasible.
作者 林学科 王佩琪 吕育纯 LIN Xueke;WANG Peiqi;LYU Yuchun(Department of Obstetrics and Gynecology,Quanzhou First Hospital Affiliated to Fujian Medical University,Quanzhou,Fujian Province,362000 China)
出处 《中外医疗》 2021年第16期110-112,共3页 China & Foreign Medical Treatment
关键词 子宫内膜异位症 亮丙瑞林 孕三烯酮片 生殖激素水平 短期复发 Endometriosis Leuprolide Gestrinone tablets Reproductive hormone levels Short-term relapse
  • 相关文献

参考文献12

二级参考文献124

共引文献1293

同被引文献54

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部